# MESALAMINE
> **ANDA203574** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2018-11-20
## Drug
- **FDA Application Number:** ANDA203574
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MESALAMINE
- **Generic name:** Mesalamine
- **Active ingredients:** MESALAMINE
- **Dosage form:** TABLET, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** MYLAN
- **First approval:** 2018-11-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203574)
---
*AI Analytics · CC0 1.0*